Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px
Financing › Details

Innova Biosciences–Genetrix (ES): investment, 201705–201707 acquisition €8m cash + 2m Sygnis shares plus up to 1.5m shares by Sygnis AG

 

Period Period 2017-05-08 ï¿½ 2017-07-05
Organisations Money taker Innova Biosciences Ltd.
  Group Genetrix (ES) (Group)
  Money source Sygnis AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard)
  Group Genetrix (ES) (Group)
Products Product Lightning-Link™ antibody labeling system
  Product 2 reagents (bio/biochemical)
Document Source Sygnis AG. (5/8/17). "Press Release: Sygnis AG Plans to Acquire Profitable Innova Biosciences Ltd. for EUR 8 Million in Cash and up to 3.5 Million Shares [Not for USA, Canada, Japan and Australia]". Madrid & Heidelberg.
     

   
Record changed: 2017-10-24

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

More documents for Genetrix (ES) (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 600x94px




» top